Recent years have seen significant strides forward in precision medicine for diabetes, a chronic disease affecting over 400 million people and causing around 2 million deaths per year globally.

Dr. Eyal Zimlichman, founder and director of ARC Innovation, a global healthcare innovation testbed, and chief innovation and transformation officer at Israel's Sheba Medical Center, is a leading ...

Precision medicine has revolutionized the landscape of neurological care, shifting from “one-size-fits-all” approaches to ...

Cutting-edge “precision medicine” has great potential to advance the diagnosis, treatment and ultimate prevention of different forms of diabetes, an international coalition of scientists reports in a ...

Baylor College of Medicine’s Center for Precision Medicine Models has received a five-year, $10 million grant from the National Institutes of Health to continue its work using precision models to ...

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher Scientific, unpacks the evolving landscape of precision therapeutic and ...

Originally developed to treat diabetes, GLP-1 agonists—now also popularly known as obesity drugs—have been making headlines for their weight-loss effects. Now, the commercial success of these GLP-1s ...

An overarching goal within modern medicine is to increase efficacy of treatment whilst decreasing off-target effects. In recent years, this has manifested through targeted therapies for many disease ...